Rwanda

in page functions
[French]
Total population (2014) 12,100,049
Birth cohort (2014) 418,199
Surviving Infants (surviving to 1 year per year, 2014) 398,511
Infant mortality rate (deaths < 1 year per 1000 births, 2012) 39/1000
Child mortality rate (deaths < 5 years per 1000 births, 2012) 55/1000
World Bank Index, IDA (2012) 3.84
Gross Nation Income (per capita US$, 2011) 560
Co-financing status (2013) Low-income
No. of districts/territories (2013) 30

GAVI support for Rwanda

Type of support

Approvals

2001-2020 (US$)
(30 Jun 2014)

Commitments

2001-2020 (US$)
(30 Jun 2014)

Disbursements

2000-2014 (US$)
(30 Jun 2014)

% Disbursed

(30 Jun 2014)
2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017
Health system strengthening (HSS 1) $5,605,000 $5,605,000 $5,605,000 100%
Health system strengthening (HSS 2) $4,439,957 $10,339,970 $2,462,813 55%
HPV (NVS) $2,895,500 $8,972,000 $2,809,087 97%
Immunisation services support (ISS) $2,958,700 $2,958,700 $2,958,700 100%
Injection safety support (INS) $369,500 $369,500 $369,500 100%
Measles-Rubella (NVS) $3,549,500 $3,549,500 $3,622,489 102%
MR - Operational costs (OPC) $3,279,500 $3,279,500 $3,279,500 100%
Penta (NVS) $42,265,255 $44,357,255 $42,660,620 101%
Pneumo (NVS) $22,370,703 $28,095,703 $23,842,323 107%
Rotavirus (NVS) $18,231,505 $23,772,005 $18,378,255 101%
Vaccine Introduction Grant (VIG) $1,065,650 $1,065,650 $1,065,650 100%
Total $107,030,771 $132,364,784 $107,053,938

Red line on table indicates duration of support based on commitments.
Commitments: Multi-year programme budgets endorsed in principle by the GAVI Board. These become financial commitments upon approval each year for the following calendar year.
Approvals: Total Approved for funding

Download data for commitments, approvals & disbursements in XLS format

Rwanda DTP3 / immunisation coverage

DTP3 - WHO/UNICEF estimates (2013)

Grade of confidence
98%

N/A
DTP3 - Official country estimates (2012) 101%
M:F sex ratio at birth (2014) 1.02
Household survey: DTP3 coverage for male (2010) 97.10%
Household survey: DTP3 coverage for female (2010) 96.50%
Household survey: Last DTP3 survey (2010) 97%
% districts achieving > 80% DTP3 coverage (2013) 100%
% districts achieving < 50% DTP3 coverage (2013) 0%
MCV WHO/UNICEF estimates (2013) 97%
Polio WHO/UNICEF estimates (2013) 98%

Breakdown of support

Non-vaccine support Vaccine support
15% 85%
$15,741,163 $91,312,773

Data refers to disbursed values, date as per above chart

Move mouse over graph for details

News and updates relating to Rwanda

08 March 2014

GAVI HPV vaccine infographic 2014 3x2

1.5 million girls set to benefit from vaccine against cervical cancer

GAVI Alliance support for national introductions marks new HPV vaccine milestone on International Women’s Day.

07 November 2013

Germany statement

GAVI Alliance welcomes Germany’s continued commitment to immunisation

German support set to benefit East African Community and help improve supply chain.

22 October 2013

UNICEF Cambodia

GAVI supports Cambodia’s campaign to vaccinate children against measles and rubella

More than four million children will receive the measles-rubella vaccine over the next three months.

close icon

modal window here